Evidence map›Paper›PMID 23797668›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2013

Distinct chemokine receptor axes regulate Th9 cell trafficking to allergic and autoimmune inflammatory sites.

Ervin E Kara, Iain Comerford, Cameron R Bastow, Kevin A Fenix, Wendel Litchfield, Tracy M Handel, Shaun R McColl

Open access · greenAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 64 citations in OpenAlex.

  1. Trial
  2. Article
  3. Th9 cells provide protective TB immunity.Frontiers in immunology · 2025
    Article
  4. Review
  5. Review
  6. Differentiation and regulation of CD4Cellular and molecular life sciences : CMLS · 2024
    Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. ACKR4 restrains antitumor immunity by regulating CCL21.The Journal of experimental medicine · 2020
    Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Atypical chemokine receptor 4 shapes activated B cell fate.The Journal of experimental medicine · 2018
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Ervin E KaraChemokine Biology Laboratory, School of Molecular and Biomedical Sciences, Discipline of Microbiology and Immunology, University of Adelaide, Adelaide, South Australia 5005, Australia.
Iain Comerford
Cameron R Bastow
Kevin A Fenix
Wendel Litchfield
Tracy M Handel
Shaun R McColl
University of Adelaide · AUUniversity of California, San Diego · US

Funding

STRUCTURE OF MACROPHAGE CHEMOTACTIC ACTIVATING PROTEINSR01AI037113 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI HANDEL, TRACY M · 1995 to 2015
$5.2M
NIAID NIH HHS R01 AI037113NIAID NIH HHS R01 AI37113
6 · The paper itself

Abstract

Migration of Th cells to peripheral sites of inflammation is essential for execution of their effector function. The recently described Th9 subset characteristically produces IL-9 and has been implicated in both allergy and autoimmunity. Despite this, the migratory properties of Th9 cells remain enigmatic. In this study, we examined chemokine receptor usage by Th9 cells and demonstrate, in models of allergy and autoimmunity, that these cells express functional CCR3, CCR6, and CXCR3, chemokine receptors commonly associated with other, functionally opposed effector Th subsets. Most Th9 cells that express CCR3 also express CXCR3 and CCR6, and expression of these receptors appears to account for the recruitment of Th9 cells to disparate inflammatory sites. During allergic inflammation, Th9 cells use CCR3 and CCR6, but not CXCR3, to home to the peritoneal cavity, whereas Th9 homing to the CNS during experimental autoimmune encephalomyelitis involves CXCR3 and CCR6 but not CCR3. To our knowledge, these data provide the first insights into regulation of Th9 cell trafficking in allergy and autoimmunity.

Indexed as

AnimalsAutoimmunityCell MovementChemotaxis, LeukocyteEncephalomyelitis, Autoimmune, ExperimentalHypersensitivityInflammationInterleukin-9MiceMice, Inbred BALB CMice, Inbred C57BLReceptors, CCR3Receptors, CCR6Receptors, CXCR3Receptors, Lymphocyte HomingT-Lymphocytes, Helper-InducerCcr3 protein, mouseCCR6 protein, mouseCxcr3 protein, mouseInterleukin-9Receptors, CCR3Receptors, CCR6Receptors, CXCR3Receptors, Lymphocyte Homing

Identifiers

PMID23797668
PMCPMC3721028
OpenAlexW2115285149

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.